Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

SAB Biotherapeutics Stock News

SABSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

SAB Biotherapeutics (SABS) Forecast

News

Earnings SAB Biotherapeutics (SABS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest SAB Biotherapeutics Stock News | NASDAQ:SABS | Benzinga

Get the latest news on SAB Biotherapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SAB Biotherapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 01, 2025

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Apr 1, 2025, 9:24AM
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - Apr 1, 2025, 7:10AM

Wednesday, January 29, 2025

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Jan 29, 2025, 11:25AM
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - Jan 29, 2025, 6:50AM

Tuesday, January 28, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jan 28, 2025, 4:06PM
Why Is SAB BIO Stock Trading Lower On Tuesday?
Vandana Singh - Jan 28, 2025, 3:40PM
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
Avi Kapoor - Jan 28, 2025, 1:46PM
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
Avi Kapoor - Jan 28, 2025, 12:20PM
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
Avi Kapoor - Jan 28, 2025, 9:44AM
SAB BIO Announces Topline Phase 1 Clinical Re...
Benzinga Newsdesk - Jan 28, 2025, 7:05AM

Thursday, November 07, 2024

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Nov 7, 2024, 9:11AM

Wednesday, November 06, 2024

SAB BIO Says Co Completed Phase 1 Enrollment ...
Benzinga Newsdesk - Nov 6, 2024, 5:33PM
SAB BIO Q3 2024 Cash, Cash Equivalents Availa...
Benzinga Newsdesk - Nov 6, 2024, 5:32PM

Friday, October 18, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Oct 18, 2024, 4:30PM

Wednesday, October 09, 2024

Craig-Hallum Initiates Coverage On SAB Biothe...
Benzinga Newsdesk - Oct 9, 2024, 8:29AM

Thursday, September 12, 2024

Oppenheimer Reiterates Outperform on SAB Biot...
Benzinga Newsdesk - Sep 12, 2024, 11:28AM

Monday, September 09, 2024

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Sep 9, 2024, 11:50AM

Wednesday, August 28, 2024

SAB Biotherapeutics shares are trading higher...
Benzinga Newsdesk - Aug 28, 2024, 10:19AM
Oppenheimer Initiates Coverage On SAB Biother...
Benzinga Newsdesk - Aug 28, 2024, 5:41AM

Monday, August 12, 2024

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Aug 12, 2024, 7:37AM
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - Aug 12, 2024, 5:45AM

Friday, August 09, 2024

SAB Biotherapeutics shares are trading lower ...
Benzinga Newsdesk - Aug 9, 2024, 1:48PM

Thursday, August 08, 2024

SAB Biotherapeutics Q2 2024 GAAP EPS $(0.79) ...
Benzinga Newsdesk - Aug 8, 2024, 6:00PM

Thursday, June 20, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 20, 2024, 8:05AM
SAB Biotherapeutics Rebrands as SAB BIO, Focu...
Benzinga Newsdesk - Jun 20, 2024, 7:24AM

Wednesday, June 19, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Jun 19, 2024, 4:30PM

Tuesday, June 18, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jun 18, 2024, 4:31PM

Friday, June 07, 2024

Brookline Capital Initiates Coverage On SAB B...
Benzinga Newsdesk - Jun 7, 2024, 6:07AM

Thursday, May 30, 2024

SAB Biotherapeutics Says CFO Michael King Wil...
Benzinga Newsdesk - May 30, 2024, 4:47PM

Thursday, May 23, 2024

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - May 23, 2024, 12:31PM

Tuesday, May 21, 2024

SAB Biotherapeutics shares are trading lower....
Benzinga Newsdesk - May 21, 2024, 12:27PM
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - May 21, 2024, 8:21AM
SAB Biotherapeutics Announces FDA Has Provide...
Benzinga Newsdesk - May 21, 2024, 7:16AM
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - May 21, 2024, 6:47AM

Monday, May 20, 2024

SAB Biotherapeutics Q1 2024 GAAP EPS $(0.43) ...
Benzinga Newsdesk - May 20, 2024, 5:49PM

Tuesday, April 16, 2024

HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - Apr 16, 2024, 1:28PM
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Apr 16, 2024, 7:41AM
SAB Biotherapeutics' Has Completed Dosing The...
Benzinga Newsdesk - Apr 16, 2024, 7:17AM

Tuesday, April 02, 2024

Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk - Apr 2, 2024, 9:17AM
HC Wainwright & Co. Maintains Buy on SAB Biot...
Benzinga Newsdesk - Apr 2, 2024, 8:40AM

Monday, March 25, 2024

SAB Biotherapeutics Announces Clinical Partne...
Benzinga Newsdesk - Mar 25, 2024, 10:16AM

Friday, February 02, 2024

SAB Biotherapeutics Says Executive Chairman S...
Benzinga Newsdesk - Feb 2, 2024, 7:52AM

Tuesday, January 23, 2024

SAB Biotherapeutics Receives Notice About Reg...
Benzinga Newsdesk - Jan 23, 2024, 5:59PM

Monday, January 08, 2024

HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk - Jan 8, 2024, 6:22AM

Friday, January 05, 2024

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor - Jan 5, 2024, 1:13PM
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk - Jan 5, 2024, 8:55AM
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk - Jan 4, 2024, 7:50PM

Wednesday, January 03, 2024

Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor - Jan 3, 2024, 2:44AM

Tuesday, January 02, 2024

SAB Biotherapeutics Announces 1-for-10 Revers...
Benzinga Newsdesk - Jan 2, 2024, 4:31PM

Monday, December 04, 2023

Biotechnology Value Fund, Reported A 5.3% Sta...
Charles Gross - Dec 4, 2023, 4:40PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved